Bristol Myers Squibb focuses on core therapeutic areas and multiple drug platforms across these areas to transform patients' lives through science and technology.

BMS is focused on core therapeutic areas and multiple drug platforms to transform patients' lives through science and technology. Learn more about our areas of interest.

Bristol Myers Squibb focuses on various therapeutic areas to transform patients' lives through science and technology.

Our relentless pursuit in research covers a wide spectrum of therapeutic areas. Discover the breadth of our research. Find and explore various clinical trials by Bristol Myers Squibb™ in several therapeutic areas.

Our vision is to discover, develop, and deliver transformational medicines. Explore our recruiting trials through our easy-to-use experience. Patients are waiting. Choose filters to find specific trials in the BMS pipeline. To search for clinical trials with other recruiting statuses, please visit bolderscience.com.

Research areas include cancer, cardiovascular disease and neuropsychiatry. Improving education and awareness helps at-risk patients have better health outcomes with early diagnosis and quality medical care. We are focused on creative solutions, new approaches and inventive concepts through health system strengthening initiatives.

We’re proud of the advancements we have made in our core therapeutic areas of oncology, hematology, immunology and cardiovascular. Our diversified and promising pipeline is focused on research in therapeutic areas where we believe we have the best opportunity to deliver transformational medicines to patients.

We are seeking a dynamic and visionary Worldwide Medical Affairs Disease Area Head (WW-DAH) to oversee our Oncology Worldwide GI, GU Cancers programs.

Bristol Myers Squibb seeks independent research applications across all therapeutic areas. Our Areas of Interest outline additional criteria to help guide the scientific community.

Here at BMS, you’ll be inspired every day by interesting and meaningful work across our therapeutic areas in early-stage and late-stage development. It’s through clinical studies, data science and our strategic operations that we lead in innovation to deliver first-in-class medicines and therapies to our patients.